Press releases

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today Health Canada approval of the BD Onclarity™ HPV...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named as one of the 100 Best Corporate Citizens of 2024 by 3BL, ranking...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic collaboration with Ypsomed...

Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ --...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its fiscal 2024 fourth quarter and full year...

Franklin Lakes, N.J. and Basel, Switzerland - Oct 08, 2024: BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ten23 health, the human-centric and...

FRANKLIN LAKES, N.J. (October 3, 2024) – BD (Becton, Dickinson and Company), a global leader in medical technology, will highlight its newest innovations in drug delivery systems at CPhI Milan 2024

No admission of liability or wrongdoing; settlement structured to eliminate uncertainty for all stakeholders related to settled cases. Settlement amount within current product litigation reserve...

FRANKLIN LAKES, N.J. (Oct. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Connor Bates has been named worldwide...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help...